Dr. Mark Bounthavong, Pharm.D., Ph.D.

Associate Professor of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences

Mark Bounthavong Photo
Mark Bounthavong, Pharm.D., Ph.D.
Email
mbounthavong@health.ucsd.edu
Support

Reimbursements

Pam Fletcher-Rice
pfletcherrice@health.ucsd.edu
858-822-6854

Human Resources

Lydia Heidt (formerly Napa)
lnapa@health.ucsd.edu
858-822-7861

Research Summary

Dr. Bounthavong’s research interests include pharmacoeconomics, program and implementation evaluations, applied econometrics, and evidence-synthesis using Bayesian methods. More recently, Dr. Bounthavong’s research has centered around evaluating academic detailing’s impact on aligning provider’s behavior with evidence-based practice, particularly with the opioid epidemic.

Academic Achievements

Education: B.S. in Biological Sciences (1999) University of California, Irvine; PharmD (2004) Western University of Health Sciences College of Pharmacy; PGY1 Pharmacy Practice Residency (2005) VA Loma Linda Medical Center; Pharmacoeconomics and Outcomes Research Fellowship (2007) Western University of Health Sciences College of Pharmacy; Master of Public Health (2013) Emory University Rollins School of Public Health; PhD (2018) University of Washington, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute.

Awards and Honors: Best Paper Award (2018) Vancouver Health Economics Methodology Meeting, Vancouver, Canada; U.S. Under Secretary of Health Pharmacy Practice Innovation Award (2009, 2017), U.S. Department of Veterans Affairs; American Society of Health-System Pharmacists Best Practice Award (2009, 2017); Alumni Achievement Award (2016) 20th Anniversary Gala Celebration. College of Pharmacy, Western University of Health Sciences; AHRQ T32 Fellowship (2013-2015) Agency for Healthcare Research and Quality T32 PhD Student training grant#T32HS013853; American Society of Health-System Pharmacists Literature (Best Paper) Award (2010); Distinguish Service Award (2009) Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific.

Leadership Experience: Associate Editor (2020-present), Substance Abuse journal (SAj) Print ISSN: 0889-7077; Online ISSN: 1547-0164; Editorial Advisory Board Member (2021-present), Journal of the American Pharmacist Association. Print ISSN: 1544-3191; Online ISSN: 1544-3450; Chair (2019-present), Pharmacy Evaluation-Research Selection Committee, VA Pharmacy Benefits Management Academic Detailing Service; Chair (2021-present) and Steering Committee Member (2018-present), New Professions Steering Committee, International Society for Pharmacoeconomics and Outcomes Research; Director, PGY1 Managed Care Pharmacy Residency (2008-2013) Veterans Affairs San Diego Healthcare System.

Teaching
  • Chair, SPPS 209 – Applied Pharmacoeconomics SPPS 209
  • Co-chair, SPPS 206 – Study Design and Biostatistics I
  • Co-chair, SPPS 208 – Study Design and Biostatistics II
Key Contributions
  • Published data used by the U.S. Office of the Inspector General’s Report on the opioid crisis
  • Implemented and maintained the first pharmacist-run immunization clinic at the Veterans Health Administration
  • Developed national formulary monographs for VA Pharmacy Benefits Management
  • Contributed (economic analysis) to the establishment of the first emergency department pharmacist position at the Veterans Health Administration